This study aims to test if a new drug, BHV-7000, works well and is safe for adults with a type of epilepsy called refractory focal onset epilepsy. Epilepsy is a brain condition that causes seizures, which are brief changes in movement, feeling, or awareness. Refractory means that seizures have not been controlled well by other medicines. Adults aged 18 to 75 who have been diagnosed with this type of epilepsy for at least a year may join. Participants must have tried at least two different seizure medications without success. They need to keep a seizure diary and can be on up to four different epilepsy treatments.
Key Points:
- Participants will need to have tried at least two anti-seizure medications before.
- They will need to keep a detailed diary of their seizures.
- People with certain types of recent surgeries or specific seizure histories cannot join.
How understandable was the trial content above?
Hard to understand
Easy to understand